NMR Group Project: Preparation and Properties of Novel M
NMR 课题组项目:Novel M 的制备及性能
基本信息
- 批准号:7291828
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
An established hallmark of tumorigenesis is the biosynthesis of aberrant glycan chains due to changes in the expression of glycoprocessing enzymes in tumor tissue. These aberrations become more marked as the tumor acquires a more aggressive phenotype. Tumor cell-surface carbohydrates play important roles in the motility and metastasis of many different cancer cells. In addition, many of these aberrant glycans are tumor-associated carbohydrate antigens (TACA) and have been used in the development of tumor vaccines. Since most of the cellular interactions with TACA's are not well understood, there is an urgent need to better characterize the specific molecular interactions that occur during these events. One feature of carbohydrate binding to macromolecules that is well understood is the concept of multivalency: Monomer carbohydrates bind to proteins very weakly while "clustering" of a monomer raises this affinity as much as a million-fold. We have prepared the important Thomsen-Friedenreich (Tf) antigen (Gal?O1-3GalNAc??-O-Ser/Thr) on very specific templates to take advantage of this so-called "cluster glycoside effect". As mentioned in the last report, we have prepared gold self-assembled nanospheres and quantum dots containing sugar derivative and reported preliminary details on their function. The in vivo experiments with our gold nanospheres in mice were repeated twice with varying results. However, these were caused by the use of a tumor cells that had had a different genetic makeup than the original and an error in the amount of tumor used. We are proceeding with a 4th study to confirm the original results along with using particles that contain simply the linker unit used to attach the sugar as a control. Our gold nanospheres containing ?O-galactose can mimic monovalent galactose in HIV cell fusion assays, also confirming the utility of these nano-constructs. We have synthesized biologically important glycopeptides and developed new linker technology to attach these to gold particles. We discovered that we need to add highly water soluble linkers to peptides that are hydrophobic to overcome the physical problems with the creation of multivalency and clustering that causes some constructs to become insoluble. In our quantum dots (qdots) work, we showed that contain Tf antigen-containing Qdots are functional but we needed to develop technology that removed the negative charge on our original design. This was accomplished and we now have a robust linker and luminescent-enhancing technology that we use to create these particles de novo in the lab. Further imaging studies with Chand Khanna at NCI have shown that these particles can label tumor cells that express galectin-3 and possible cause these cells to become apoptotic. We are continuing these studies with several collaborators. In this past year, we spent half of the time without a full time researcher since the original post doc who developed most of the work left the NCI suddenly and the timing to secure another able fellow delayed the work. We are now synthesizing additional particles to supply our collaborators for further biological characterization.
肿瘤发生的既定标志是由于肿瘤组织中糖化酶表达的变化,异常聚糖链的生物合成。随着肿瘤获得更具侵略性的表型,这些畸变变得更加明显。肿瘤细胞表面碳水化合物在许多不同癌细胞的运动性和转移中起着重要作用。此外,这些异常的聚糖中的许多是与肿瘤相关的碳水化合物抗原(TACA),并且已用于肿瘤疫苗的发育。由于大多数与TACA的细胞相互作用尚不清楚,因此迫切需要更好地表征这些事件中发生的特定分子相互作用。碳水化合物与大分子结合的特征是多价性的概念:单体碳水化合物与蛋白质的结合非常弱,而单体“聚类”会提高这种亲和力多达一百万倍。我们已经在非常具体的模板上准备了重要的Thomsen-Friedenreich(TF)抗原(Gal?o1-3galnac ?? - O-Ser/Thr),以利用这种所谓的“簇糖苷效应”。正如上一报告所述,我们已经准备了金纳米球和量子点,这些纳米球和量子点含有糖衍生物,并报告了有关其功能的初步细节。在小鼠中与我们的金纳米球进行体内实验,重复两次,结果不同。但是,这些是由于使用与原始肿瘤构成不同的肿瘤细胞以及所用肿瘤量的误差所致。我们正在进行第四次研究,以确认原始结果,并使用仅包含用于将糖作为对照的接头单元的粒子。我们的金纳米球含有o-半乳糖,可以模仿HIV细胞融合分析中的单价半乳糖,也可以证实这些纳米构造的实用性。我们已经合成了具有生物学上重要的糖肽,并开发了新的接头技术以将其连接到黄金颗粒上。我们发现,我们需要将高度水溶性的接头添加到疏水性的肽中,以克服多种关系和聚类的物理问题,从而导致某些构建体变得不溶。在我们的量子点(QDOTS)工作中,我们表明包含含TF抗原的QDOT具有功能性,但我们需要开发技术,以消除原始设计的负电荷。这是完成的,我们现在拥有强大的接头和发光的技术,我们用来在实验室中创建这些粒子。 NCI的Chand Khanna进行进一步的成像研究表明,这些颗粒可以标记表达乳肠蛋白3的肿瘤细胞并可能导致这些细胞凋亡。我们正在与几位合作者继续进行这些研究。在过去的一年中,我们花了一半的时间没有全职研究人员,因为原始的帖子文档开发了大部分作品,突然间,NCI突然离开了NCI,并确保另一个有能力的人推迟了工作。现在,我们正在合成其他粒子,以提供我们的合作者以进一步的生物学表征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph John Barchi其他文献
Joseph John Barchi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph John Barchi', 18)}}的其他基金
NMR Group Project: Structural Analysis of Conformational
NMR 小组项目:构象的结构分析
- 批准号:
6763822 - 财政年份:
- 资助金额:
-- - 项目类别:
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines
用于抗粘连剂和肿瘤疫苗的携带碳水化合物抗原的纳米颗粒
- 批准号:
8552700 - 财政年份:
- 资助金额:
-- - 项目类别:
NMR Group Project: Biophysical Studies of Oligonucleotid
NMR 小组项目:寡核苷酸的生物物理研究
- 批准号:
7053872 - 财政年份:
- 资助金额:
-- - 项目类别:
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy
用于抗肿瘤治疗的碳水化合物抗原纳米颗粒
- 批准号:
10702356 - 财政年份:
- 资助金额:
-- - 项目类别:
Structural Studies of Drug Agents by Nuclear Magnetic Resonance Spectroscopy
通过核磁共振波谱法研究药物的结构
- 批准号:
7733184 - 财政年份:
- 资助金额:
-- - 项目类别:
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy
用于抗肿瘤治疗的碳水化合物抗原纳米颗粒
- 批准号:
10014373 - 财政年份:
- 资助金额:
-- - 项目类别:
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy
用于抗肿瘤治疗的碳水化合物抗原纳米颗粒
- 批准号:
10262091 - 财政年份:
- 资助金额:
-- - 项目类别:
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines
用于抗粘连剂和肿瘤疫苗的携带碳水化合物抗原的纳米颗粒
- 批准号:
8175324 - 财政年份:
- 资助金额:
-- - 项目类别:
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
来自间质性膀胱炎患者的糖肽作为新型抗癌先导药物
- 批准号:
10702513 - 财政年份:
- 资助金额:
-- - 项目类别:
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
来自间质性膀胱炎患者的糖肽作为新型抗癌先导化合物
- 批准号:
7966267 - 财政年份:
- 资助金额:
-- - 项目类别:
相似国自然基金
信息交流对异质性团体感知觉决策的影响研究:基于认知计算的动态优势表征
- 批准号:32300910
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
团体创新中的观念生成路径及其神经基础研究
- 批准号:32300900
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于时间的团体竞争:连续时间框架下的理论和实验分析
- 批准号:72373069
- 批准年份:2023
- 资助金额:41.00 万元
- 项目类别:面上项目
一类特殊Abelian群的子群计数问题
- 批准号:12301006
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于分子互作研究多酚结构差异对面团体系面筋蛋白网络形成的调控机制
- 批准号:32301998
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Innovative Tools for Chemical Synthesis: Metal-Hydride Catalysis, Medicinal Motifs, and Molecular Probes
化学合成的创新工具:金属氢化物催化、药用基序和分子探针
- 批准号:
10624041 - 财政年份:2018
- 资助金额:
-- - 项目类别:
North American Mitochondrial Disease Consortium (NAMDC)
北美线粒体疾病联盟 (NAMDC)
- 批准号:
8339450 - 财政年份:2011
- 资助金额:
-- - 项目类别:
North American Mitochondrial Disease Consortium (NAMDC)
北美线粒体疾病联盟 (NAMDC)
- 批准号:
8537981 - 财政年份:2011
- 资助金额:
-- - 项目类别: